Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Current Drug Targets|June 26, 2004
Development of new drugs in angiogenesisMarina Ziche, Sandra Donnini, Lucia Morbidelli
International Journal of Molecular Sciences|December 23, 2022
Anti-Inflammatory Effect of the Natural H<sub>2</sub>S-Donor Erucin in Vascular EndotheliumValerio Ciccone, Eugenia Piragine, Era Gorica, et al.
Antioxidants (Basel, Switzerland)|July 2, 2021
The H<sub>2</sub>S-Donor Erucin Exhibits Protective Effects against Vascular Inflammation in Human Endothelial and Smooth Muscle CellsAlma Martelli, Eugenia Piragine, Era Gorica, et al.
Biomarker Insights|June 16, 2017
Influence of Circulating Endothelin-1 and Asymmetric Dimethylarginine on Whole Brain Circulation Time in Multiple SclerosisLucia Monti, Lucia Morbidelli, Lorenzo Bazzani, et al.
Pharmacological Research|September 22, 2016
H<sub>2</sub>S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wallMartina Monti, Erika Terzuoli, Marina Ziche, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 5, 2009
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talkSandra Donnini, Erika Terzuoli, Marina Ziche, et al.
Pharmacological Research|August 23, 2013
The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosisMartina Monti, Erika Terzuoli, Marina Ziche, et al.
Biomedicines|January 18, 2020
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in AgeingGinevra Nannelli, Marina Ziche, Sandra Donnini, et al.
Pageof 12